TROSUNILIMAB
UNII LNN5K7KB5R

Substance Identification & Data

This profile provides standardized clinical and technical data for Trosunilimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) LNN5K7KB5R.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2550297-60-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

LNN5K7KB5R

CAS Registry Number

2550297-60-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TROSUNILIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C207007

National Cancer Institute reference terminology for clinical and research data.

INN ID

12071

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

NO-39

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Trosunilimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TROSUNILIMAB

Common Names & Synonyms

ABBV 382 [WHO-DD]

GAMMA1 HEAVY CHAIN (1-442) (VH (HOMO SAPIENS IGHV1-69*11 (80.0%) -(IGHD) -IGHJ3*01 (92.3%) M123>T (107), CDR-IMGT (8.8.5) (26-33.51-58.97-101)) (1-112) -HOMO SAPIENS IGHG1*03V, G1M3>G1M17, NG1M1 (CH1 R120>K (209) (113-210), HINGE 1-15 (211-225), CH2 (226-335), CH3 E12 (351), M14 (353) (336-440), CHS (441-442)) (113-442)), (215-214')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-214') (V-KAPPA MUSMUS/HOMSAP (MUS MUSCULUS IGKV14-100*01 (85.3%) -IGKJ1*01 (91.7%) L124>V (104)/HOMO SAPIENS IGKV1-33*01 (80.0%) -IGKJ4*01 (100%), CDR-IMGT (6.3.9) (27-32.50-52.89-97)) (1'-107') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153), V101 (191) (108'-214')); DIMER (221-221'':224-224'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, GLYCOFORM ALFA

IMMUNOGLOBULIN G1, ANTI-(HUMAN INTEGRIN .ALPHA.4.BETA.7) (HUMAN-MUS MUSCULUS MONOCLONAL PR-1794842 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL PR-1794842 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS INTEGRIN ITGA4_ITGB7 (INTEGRIN ALPHA4 (CD49D)_BETA7, INTEGRIN .ALPHA.4.BETA.7, LYMPHOCYTE PEYER'S PATCH ADHESION MOLECULE 1, LPAM-1))

TROSUNILIMAB [INN]

TROSUNILIMAB [USAN]